Oral pharmaceutical formulation containing ibandronate

Oral pharmaceutical formulation containing ibandronate

  • CN 101,152,160 A
  • Filed: 04/21/1997
  • Published: 04/02/2008
  • Est. Priority Date: 04/20/1996
  • Status: Abandoned Application
First Claim
Patent Images

1. contain the salt that can tolerate on ibandronate or its physiology oral drugs form of administration as active substance, it is characterized in that, the interior layer segment that this form of administration is sealed by the coating material that is not contained active substance that contains active substance is formed, and this sealing can make active component generation rapid release.

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×